| |
Population
|
Panel
|
Percentage expressed in
|
|---|
|
In vitro analysis
|
Enriched HSC
|
CD45/34/90
|
CD45
|
|
Myeloid progenitor
|
CD45/34hi/33
|
Cells
|
|
Myeloid precursor
|
CD45/34lo/33
|
Cells
|
|
Monocyte lineage
|
CD45/34–/33/14
|
Cells
|
|
Neutrophil lineage
|
CD45/34–/14–/33
|
Cells
|
|
B-lymphocyte progenitor
|
CD45/34/10/19
|
CD45
|
|
B-lymphocyte lineage
|
CD45/10/19
|
CD45
|
|
Megakaryocyte precursor
|
CD45/34/41/42
|
Cells
|
|
Immature platelet
|
CD45/41/42
|
Cells
|
|
Erythroid lineage
|
CD45/36/235a
|
Cells
|
|
Immature erythrocyte
|
CD45–/36/235a
|
Cells
|
|
Mice analysis
|
Hematopoietic cells
|
CD45
|
Cells
|
|
HSPCs
|
CD45/34
|
CD45
|
|
Enriched HSC
|
CD45/34hi
|
CD45
|
|
HSC
|
CD45/34/38–/90/45RA–
|
CD34
|
|
MPP
|
CD45/34/38–/90–/45RA–
|
CD34
|
|
CLP
|
CD45/34/10
|
CD34
|
|
GMP
|
CD45/34/10–/38/135/45RA
|
CD34
|
|
CMP
|
CD45/34/10–/38/135/45RA–
|
CD34
|
|
MEP
|
CD45/34/10–/38/135–/45RA–
|
CD34
|
|
T-lymphocyte progenitor
|
CD45/34/10–/19–/7
|
CD34
|
|
B-lymphocyte progenitor
|
CD45/34/10/19/7–
|
CD34
|
|
B-lymphocyte
|
CD45/34–/19/7–
|
CD45
|
|
Myeloid progenitor
|
CD45/34hi/33
|
CD34
|
|
Myeloid precursor
|
CD45/34lo/33/15
|
CD34
|
|
Dendritic cell
|
CD45/34–/14/15–/11b/11c
|
CD45
|
|
Monocyte
|
CD45/34–/33/14/15–
|
CD45
|
|
Neutrophil
|
CD45/34–/33/14–/15
|
CD45
|
|
Megakaryocyte precursor
|
CD45/34/41a/42
|
CD45
|
|
Platelet
|
CD45–/41a/42
|
Cells
|
|
Erythroid lineage
|
CD45/36/235a
|
CD45
|
|
Erythrocyte
|
CD45–/235a
|
Cells
|
-
CD cluster of differentiation, CLP common lymphoid progenitor cells, CMP common myeloid progenitor cells, GMP granulocyte macrophage progenitor cells, hi high, HSC hematopoietic stem cells, HSPC hematopoietic stem cell and progenitor cell, lo low, MEP megakaryocyte erythroid progenitor cells, MPP multipotent progenitor cells
